This content is protected - please log in with your customer account to continue.
Reset your password
We will send you an email to reset your password
Login
If you have an account with us, please log in.
Welcome to Prime BioGroup!
This content is protected - please log in with your customer account to continue.
We will send you an email to reset your password
If you have an account with us, please log in.
Orders placed by 6:00PM ship the next business day.
Orders are shipped Monday through Thursday only.
Most orders are processed and shipped within 1 business day after being placed.
We do not ship on Fridays, weekends, or federal holidays to prevent packages from being held in transit.
Monday - Thursday
8:30am - 3:00pm MST
Your cart is currently empty.
Not sure where to start? Try these collections:
Vendor: Prime Peptides
Available in stock (660)
GLP-3 is a novel investigational peptide that functions as a triple agonist, targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. This multi-receptor activity is designed to enhance metabolic regulation by improving insulin sensitivity, reducing appetite, increasing energy expenditure, and promoting weight reduction.
In research settings, GLP-3 has been studied for its ability to deliver greater efficacy in weight management and glycemic control compared to single- or dual-agonist therapies. By engaging three distinct pathways, GLP-3 may provide synergistic benefits for metabolic health, making it a key focus in obesity and type 2 diabetes research.
Potential applications of GLP-3 peptide research include:
✔ Weight management studies with superior reductions in body fat and appetite suppression
✔ Type 2 diabetes research focused on glycemic control and insulin sensitivity
✔ Metabolic health studies exploring energy expenditure and improved lipid profiles
✔ Cardiovascular risk reduction research through comprehensive metabolic regulation
